CardioGenics Holdings (CardioGenics Holdings) Days Sales Outstanding : 0.00 (As of Jan. 2016)

View and export this data going back to 2004. Start your Free Trial

What is CardioGenics Holdings Days Sales Outstanding?

CardioGenics Holdings's average Accounts Receivable for the three months ended in Jan. 2016 was $0.38 Mil. CardioGenics Holdings's Revenue for the three months ended in Jan. 2016 was $0.00 Mil.

The historical rank and industry rank for CardioGenics Holdings's Days Sales Outstanding or its related term are showing as below:

CGNH's Days Sales Outstanding is not ranked ^*
in the Medical Diagnostics & Research industry.
Industry Median: 69.88
* Ranked among companies with meaningful Days Sales Outstanding only.

CardioGenics Holdings's Days Sales Outstanding stayed the same from Jan. 2015 (0.00) to Jan. 2016 (0.00).

CardioGenics Holdings Days Sales Outstanding Historical Data

The historical data trend for CardioGenics Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CardioGenics Holdings Days Sales Outstanding Chart

CardioGenics Holdings Annual Data

Trend

Jul06

Jul07

Jul08

Oct09

Oct10

Oct11

Oct12

Oct13

Oct14

Oct15

Days Sales Outstanding

Get a 7-Day Free Trial

2,514.44

3,285.00

CardioGenics Holdings Quarterly Data
	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13	Jan14	Apr14	Jul14	Oct14	Jan15	Apr15	Jul15	Oct15	Jan16
Days Sales Outstanding	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CardioGenics Holdings's Days Sales Outstanding

For the Diagnostics & Research subindustry, CardioGenics Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CardioGenics Holdings's Days Sales Outstanding Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CardioGenics Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where CardioGenics Holdings's Days Sales Outstanding falls into.

CardioGenics Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

CardioGenics Holdings's Days Sales Outstanding for the fiscal year that ended in Oct. 2015 is calculated as

	Days Sales Outstanding (A: Oct. 2015 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2014 )	+	Accounts Receivable (A: Oct. 2015 ))	/	count )	/	Revenue (A: Oct. 2015 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	0	*	365
=	0					/	0	*	365
=	N/A

CardioGenics Holdings's Days Sales Outstanding for the quarter that ended in Jan. 2016 is calculated as:

	Days Sales Outstanding (Q: Jan. 2016 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Oct. 2015 )	+	Accounts Receivable (A: Jan. 2016 ))	/	count )	/	Revenue (A: Jan. 2016 )	*	Days in Period
=	( (0	+	0.38)	/	1 )	/	0	*	365 / 4
=	0.38					/	0	*	365 / 4
=	N/A

CardioGenics Holdings (OTCPK:CGNH) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

CardioGenics Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of CardioGenics Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

CardioGenics Holdings (CardioGenics Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » CardioGenics Holdings Inc (OTCPK:CGNH) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

6295 Northam Drive, Unit 8, Mississauga, ON, CAN, L4V 1W8

Website

http://www.cardiogenics.com

CardioGenics Holdings Inc is a biotechnology company. It is engaged in the development and commercialization of diagnostic test products for the In-Vitro Diagnostics (IVD) testing market. The company's objective is to create, develop and commercialize superior, innovative, cost-effective and patent-protected products for the IVD based on proprietary technologies. Its products include QL Care Analyzer, Immunoassay Tests, and Paramagnetic Beads. The business activity is primarily carried out through the region of Canada.

CardioGenics Holdings (CardioGenics Holdings) Headlines

No Headlines